New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
24 April 2019, Charlottesville: GIDI Spring Symposium #536
Comments
Program skeleton: https://gidi.virginia.edu/2019-gidi-symposium Registration now open: https://gidi.virginia.edu/2019-gidi-symposium-registration-form . I just registered. |
Apparently, there was a Zika brewing session in November 2018. Need to find out details. |
Now lightning talks (none of the slides are available)
|
|
|
|
|
Richard Karl Deang, anthropologist on peer counseling around HIV prevention
|
|
Now Peter Kasson on cases where moderate pre-existing immunity can worsen outcomes due to cross-reactions, e.g. between Zika and Dengue
|
Scholia profiles updated:
|
Missing from the first round of lightning talks: Volkan Koseoglu on the extracellular lifestyle of an intracellular pathogen |
Coffee break |
Now onto the keynote by Carolyn Reynolds, a UVA alumna: What the World (Still) Needs to Do to Prevent the Next Pandemic
Now her priorities derived from those experiences:
In closing, she makes multiple comparisons between preparedness for military and pandemic threats, especially in Virginia with its strong military presence/ roots/ culture. Closes off with reference to the 1918 pandemic |
Now on to the 2nd round of Lightning talks
No results shown. |
Martin Wu, Resistance prediction of Clostridium difficile infection
In clinical practice, anibiotic resistance is not routinely tested, even though antibiotic failure rate is high (ca. 1/3) Nice slide with bacterial composition in the stool of one patient, including 0.14 percent C. difficile. Top one was Akkermansia muciniphila. Needs info on the genes that are involved in conferring resistance. Signs of emerging resistance to Vancomycin and Fidaxomicin (which targets RNA polymerase). |
Gregory Maddon: Cost of overtesting and overdiagnosing of C. difficile antibiotic resistance No FDA-approved test to diagnose C. difficile infection (as opposed to colonization by C. difficile). PCR Cycle threshold as a predictor of C. difficile toxin levels |
Md Amzad Hussein on Impact of Community Clinics on Health outcome, based on a field study in Bangladesh
|
Kate McManus: HIV and health insurance (in the US)
|
Now Jason Papin on antibiotic resistance "in the wild" (i.e. as opposed to very controlled laboratory conditions)
|
Angelina Angelucci on inflammasomes in congenital Zika virus infection
|
Now Volkan Köseoğlu on the extracellular lifestyle of an intracellular pathogen, who was originally (on paper) scheduled in the first session Shigella infections and IcsA Actin based motility, bile salts, biofilm formation in small intestine and colon Q: Does Shigella develop biofilms under flow? Q: Does IcsA have a role in this biofilm formation? Reminds me of the biofilm MRI my colleagues did back at IBMT |
as per https://twitter.com/GIDIuva/status/1075008121557393408 . Details forthcoming.
The text was updated successfully, but these errors were encountered: